CymaBay Therapeutics Presents Data Showing Seladelpar Treatm

Additional data presented at The International Liver Congress™ 2023 show clinical risk factors for PBC disease progression present in a broader population of UDCA-treated PBC... | June 21, 2023

Related Keywords

United States , Hans Vitzthum , International Liver Congress , Twitter , European Medicines Agency , Drug Administration , Prnewswire Cymabay Therapeutics Inc , Cymabay Therapeutics Inc , Exchange Commission , Nasdaq , Lifesci Advisors , Linkedin , Bay Therapeutics , European Association , Novel Pathways , Priority Medicines , Annual Report , Relations Contact , Sci Advisors , Cymabay Therapeutics , Nc Stock Exchange , News , Information , Press Release , Dditional , Data , Resented , It , The , Nternational , Liver , 023 , Show , Linical , Risk , Actors , Or , Abc , Disease , Progression , Present , N , Broader , Population , F Cbay Us23257d1037 ,